CONMED CNMD Deferred Foreign Income Tax Expense Benefit
Deferred Foreign Income Tax Expense Benefit at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:DeferredForeignIncomeTaxExpenseBenefit.
The official record: CONMED’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about CONMED's deferred foreign income tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CONMED's deferred foreign income tax expense benefit?
- CONMED (CNMD) reported deferred foreign income tax expense benefit of -$349K in Q4 2025.
- How has CONMED's deferred foreign income tax expense benefit changed year-over-year?
- CONMED's deferred foreign income tax expense benefit decreased by 219.3% year-over-year, from $292.5K to -$349K.
- What is the long-term trend for CONMED's deferred foreign income tax expense benefit?
- Over 4 years (2021 to 2025), CONMED's deferred foreign income tax expense benefit has grown at a -7.5% compound annual growth rate (CAGR), from -$1.91M to -$1.4M.
- What does deferred foreign income tax expense benefit mean?
- Represents the net change in deferred tax positions related to international operations, accounting for timing differences between book income and taxable income in foreign jurisdictions. This is critical for assessing the long-term tax profile of a company's global footprint.